Our clinical study explores the effectiveness of an Artificial Intelligence (AI)-driven personalised diet for Irritable Bowel Syndrome (IBS) patients. The research highlights how a tailored nutritional approach, guided by individual gut microbiome profiles, significantly improves IBS symptoms compared to a standard IBS diet. Over a six-week period, patients receiving the personalised AI-based diet experienced notable reductions in pain, discomfort, and bloating, leading to improved quality of life. This innovative solution harnesses the power of microbiome analysis to create precise dietary interventions, offering a promising new way to manage IBS.
Key Benefits of Microbiome Testing from the Research:
- Tailored Dietary Plans: Microbiome analysis enables personalised diets that are optimised for each individual's gut health.
- Significant Symptom Reduction: The AI-based personalised diet reduced IBS severity from severe to moderate in 78% of patients.
- Improved Gut Bacteria Composition: The study showed a statistically significant increase in beneficial gut bacteria like Faecalibacterium and Propionibacterium in the personalised diet group.
- Higher Improvement in IBS Symptom Scores: Patients on the personalised diet saw a greater reduction in IBS Symptom Severity Scores (IBS-SSS) compared to those on a standard diet.
- Enhanced Quality of Life: The personalised diet led to substantial improvements in patients’ pain severity, bloating, and overall satisfaction with bowel habits.
- Long-Term Gut Health: AI-based diets promote healthy modulation of gut bacteria, creating lasting benefits for digestive health beyond symptom management.
